Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

Nexuswelt – EU Funding & Innovation Agency

Company (SME)

nexuswelt.com/München, Germany
1 profile visit

About

Nexuswelt is a German SME supporting European R&I projects as an active consortium partner.
We contribute to:
• patient, healthcare and stakeholder engagement
• communication and dissemination
• exploitation, innovation uptake and sustainability
• capacity building and training coordination
• replication and scaling
• digital health adoption and implementation support
• project management and delivery
Nexuswelt has experience in EU-funded health and cancer-related projects, including the Cancer Mission project SHIELD.
We are interested in joining existing or forming Cluster Health and Mission Cancer consortia as a funded partner with a clearly defined role in stakeholder engagement, exploitation and uptake, capacity building, dissemination and project delivery.

Representatives

Founder & Managing Director

Nexuswelt – EU Funding & Innovation Agency

Marketplace (1)

  • Project cooperation

    German SME seeking Health & Cancer Mission consortium

    We contribute to stakeholder and patient engagement, exploitation and innovation uptake, capacity building, dissemination, replication, digital-health adoption and project delivery.

    • Partner seeks Consortium/Coordinator
    • Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
    • Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
    • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
    • Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
    Author

    Founder & Managing Director at Nexuswelt – EU Funding & Innovation Agency

    München, Germany